文献速递消化、代谢与肾脏急症儿科与产科急症呼吸衰竭与机械通气

重新评估儿童糖尿病酮症酸中毒的碳酸氢盐治疗:神经与呼吸结局的倾向性评分匹配分析

Reevaluating bicarbonate therapy in pediatric DKA: A propensity score-matched analysis of neurological and respiratory outcomes.
PubMed 文献 · Am J Emerg Med · 2025-07-14
一句话结论儿童糖尿病酮症酸中毒中使用碳酸氢盐未增加脑水肿风险,但与昏迷、肺水肿和急性呼吸衰竭风险升高相关,提示临床应谨慎使用。

本研究为回顾性队列研究,使用TriNetX全球去标识电子健康记录网络,纳入12岁以下儿童糖尿病酮症酸中毒患者,按是否接受碳酸氢盐治疗分组并进行倾向性评分匹配。匹配后每组各211例。结果显示两组脑水肿风险无显著差异(RD=0.002;95%CI:-0.039至0.044;p=0.911),但碳酸氢盐使用与昏迷风险升高(RD=0.047;p=0.001)、肺水肿风险升高(RD=0.048;p=0.001)和急性呼吸衰竭风险升高(RD=0.071;p=0.008)相关。作者认为临床医生应谨慎使用碳酸氢盐,当前治疗指南可能需要重新评估。

要点

  • 匹配后每组211例,碳酸氢盐组脑水肿风险与对照组无显著差异(RD=0.002;95%CI:-0.039至0.044;p=0.911)。
  • 碳酸氢盐组昏迷风险较对照组升高(RD=0.047;p=0.001)。
  • 碳酸氢盐组肺水肿风险较对照组升高(RD=0.048;p=0.001)。
  • 碳酸氢盐组急性呼吸衰竭风险较对照组升高(RD=0.071;p=0.008)。
  • 作者认为临床医生应谨慎使用碳酸氢盐,当前治疗指南可能需要重新评估。

适用人群与场景

  • 12岁以下儿童糖尿病酮症酸中毒患者,来自TriNetX全球去标识电子健康记录网络。

研究设计与关键结果

  • 回顾性队列研究,使用TriNetX全球研究网络,纳入12岁以下儿童糖尿病酮症酸中毒患者,按碳酸氢盐治疗状态分层并经倾向性评分匹配。
  • 匹配后每组各211例。
  • 脑水肿风险两组无显著差异(RD=0.002;95%CI:-0.039至0.044;p=0.911)。
  • 碳酸氢盐使用与昏迷风险升高相关(RD=0.047;p=0.001)。
  • 碳酸氢盐使用与肺水肿风险升高相关(RD=0.048;p=0.001)。
  • 碳酸氢盐使用与急性呼吸衰竭风险升高相关(RD=0.071;p=0.008)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床医生应谨慎使用碳酸氢盐,当前治疗指南可能需要重新评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes mellitus, responsible for up to 40 % of diabetes-related morbidity and mortality. Despite its use in severe cases of pediatric DKA, bicarbonate therapy remains controversial due to potential associations with adverse outcomes such as cerebral edema.

OBJECTIVES: Prior studies evaluating bicarbonate therapy in pediatric DKA have been limited by confounding variables, small sample sizes, and short follow-up periods. This study aims to evaluate the association between bicarbonate therapy and adverse outcomes using a large clinical dataset, extended follow-up, and propensity score (PS) matching to control for baseline differences.

METHODS: We conducted a retrospective cohort study using TriNetX, a global research network of deidentified electronic health records. Pediatric DKA patients (<12 years) were stratified by bicarbonate therapy status and matched using PS to reduce confounders. Risk analysis was conducted to assess clinical outcomes.

RESULTS: After PS matching, each cohort included 211 patients. No significant difference in cerebral edema was observed between groups (RD = 0.002; 95 % CI: -0.039 to 0.044; p = 0.911). However, bicarbonate use was associated with higher risks of coma (RD = 0.047; p = 0.001), pulmonary edema (RD = 0.048; p = 0.001), and acute respiratory failure (RD = 0.071; p = 0.008).

CONCLUSION: Although bicarbonate therapy was not linked to increased cerebral edema, it was associated with significant respiratory and neurologic complications. These findings suggest that clinicians should use bicarbonate cautiously and that current treatment guidelines may warrant reevaluation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Patel M, Afifi AM, Hercher RL, et al. Reevaluating bicarbonate therapy in pediatric DKA: A propensity score-matched analysis of neurological and respiratory outcomes. Am J Emerg Med. 2025. PMID: 40683034. doi:10.1016/j.ajem.2025.07.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。